81 - 90 of 7877 Results
Title
Year
- Characterizing a complex CT-rich haplotype in intron 4 of SNCA using large-scale targeted amplicon long-read sequencing2024OPENTitle: Characterizing a complex CT-rich haplotype in intron 4 of SNCA using large-scale targeted amplicon long-read sequencingJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00749-4Citation Count: 0
-
OPENTitle: Parkinson's Disease Gene Screening in Familial Cases from Central and South AmericaJournal Name: Movement DisordersPublisher: WileyVol: 39Issue #: 10Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29931Citation Count: 0
-
RESTRICTEDTitle: Cognitive dysfunction in animal models of human lewy-body dementiaJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 16Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3389/fnagi.2024.1369733Citation Count: 0
- The activities of daily living partially mediate the relationship between rapid eye movement sleep behavior disorder and depressive symptoms in Parkinson's disease2024OPENTitle: The activities of daily living partially mediate the relationship between rapid eye movement sleep behavior disorder and depressive symptoms in Parkinson's diseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 15Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2024.1357721Citation Count: 0
- Unfolded protein response markers Grp78 and eIF2alpha are upregulated with increasing alpha‐synuclein levels in Lewy body disease2024OPENTitle: Unfolded protein response markers Grp78 and eIF2alpha are upregulated with increasing alpha‐synuclein levels in Lewy body diseaseJournal Name: Neuropathology and Applied NeurobiologyPublisher: WileyVol: 50Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/nan.12999Citation Count: 0
- Adult-onset deletion of ATP13A2 in mice induces progressive nigrostriatal pathway dopaminergic degeneration and lysosomal abnormalities2024OPENTitle: Adult-onset deletion of ATP13A2 in mice induces progressive nigrostriatal pathway dopaminergic degeneration and lysosomal abnormalitiesJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00748-5Citation Count: 1
- Modeling of Parkinson’s Disease Progression and Implications for Detection of Disease Modification in Treatment Trials2024OPENTitle: Modeling of Parkinson’s Disease Progression and Implications for Detection of Disease Modification in Treatment TrialsJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 14Issue #: 6Start Page: 1End Page: 11Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-230446Citation Count: 0
-
OPENTitle: Targeted co-expression networks for the study of traitsJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-024-67329-7Citation Count: 0
- [18F]Flotaza for Aβ Plaque Diagnostic Imaging: Evaluation in Postmortem Human Alzheimer’s Disease Brain Hippocampus and PET/CT Imaging in 5xFAD Transgenic Mice2024OPENTitle: [18F]Flotaza for Aβ Plaque Diagnostic Imaging: Evaluation in Postmortem Human Alzheimer’s Disease Brain Hippocampus and PET/CT Imaging in 5xFAD Transgenic MiceJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 25Issue #: 14Start Page: 7890End Page: 7890Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms25147890Citation Count: 0
-
RESTRICTEDTitle: Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2024 UpdateJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 14Issue #: 5Start Page: 1End Page: 14Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3233/jpd-240272Citation Count: 0